Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Avery

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|March 26, 2011
Warfarin treatment outcomes in children monitored at home with a point-of-care deviceT Biss, P J Avery, P M Walsh, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2011
Comparison of time within therapeutic INR range with percentage INR within therapeutic range for assessing long-term anticoagulation control in children: reply to a rebuttalT T Biss, P J Avery, P M Walsh, et al.
Journal of Thrombosis and Haemostasis : JTH|May 10, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot studyE A Sconce, P J Avery, H A Wynne, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2011
Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in childrenT T Biss, P J Avery, P M Walsh, et al.
Journal of Human Hypertension|January 4, 2008
Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family studyT Rahman, M Baker, D H Hall, et al.
Clinical Pharmacology and Therapeutics|October 21, 2011
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapyP J Avery, A Jorgensen, A K Hamberg, et al.
Journal of Human Hypertension|January 21, 2011
Common variation in the adiponectin gene has an effect on systolic blood pressureP J Avery, S K Patel, I M Ibrahim, et al.
Diabetologia|April 30, 1998
Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistanceC P Day, J Grove, A K Daly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1996
Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM familiesM Armstrong, F Haldane, P J Avery, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in childrenT T Biss, P J Avery, M D Williams, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|March 26, 2011
Warfarin treatment outcomes in children monitored at home with a point-of-care deviceT Biss, P J Avery, P M Walsh, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2011
Comparison of time within therapeutic INR range with percentage INR within therapeutic range for assessing long-term anticoagulation control in children: reply to a rebuttalT T Biss, P J Avery, P M Walsh, et al.
Journal of Thrombosis and Haemostasis : JTH|May 10, 2008
Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot studyE A Sconce, P J Avery, H A Wynne, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2011
Comparison of 'time within therapeutic INR range' with 'percentage INR within therapeutic range' for assessing long-term anticoagulation control in childrenT T Biss, P J Avery, P M Walsh, et al.
Journal of Human Hypertension|January 4, 2008
Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family studyT Rahman, M Baker, D H Hall, et al.
Clinical Pharmacology and Therapeutics|October 21, 2011
A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapyP J Avery, A Jorgensen, A K Hamberg, et al.
Journal of Human Hypertension|January 21, 2011
Common variation in the adiponectin gene has an effect on systolic blood pressureP J Avery, S K Patel, I M Ibrahim, et al.
Diabetologia|April 30, 1998
Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistanceC P Day, J Grove, A K Daly, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1996
Relationship between insulin sensitivity and insulin receptor substrate-1 mutations in non-diabetic relatives of NIDDM familiesM Armstrong, F Haldane, P J Avery, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2013
The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in childrenT T Biss, P J Avery, M D Williams, et al.
Pageof 3